hn.today

Eye Cells May Have Been Rejuvenated for the First Time in People

time.com11 points1 comments
Screenshot of Eye Cells May Have Been Rejuvenated for the First Time in People

Researchers tested a novel partial cellular reprogramming therapy in people with glaucoma that aims to rejuvenate retinal ganglion cells and restore their ability to transmit visual signals. Building on Yamanaka factor technology, the team delivered three transcription-factor genes (a modified set of the four Yamanaka factors) as proteins into the eye’s vitreous to shift damaged cells back to a more youthful, functional state without reverting them fully to embryonic-like cells. The approach was developed from David Sinclair’s epigenetic-noise theory and mouse work by Yuancheng Lu that regenerated ganglion cell connections; removing the fourth factor reduces cancer risk and allowed packaging into viral tools. The trial is a Phase 1 FDA-approved safety study in people with glaucoma.

Three participants received the injection and activated the factors by taking doxycycline for eight weeks, which functions as an on-off switch for the treatment. Researchers report no reprogramming-related adverse effects, only injection-related side effects, and early functional gains: two of three participants showed measurable improvement on visual-field tests eight weeks post-treatment. Investigators plan to test a higher dose and expand into other eye conditions such as NAION; preclinical data also suggest potential applicability to brain, liver, joint and other age-related tissues.

Read on time.com1 comments on Hacker News

Summary generated by AI from the linked article. hn.today is not affiliated with Hacker News or Y Combinator.

More in Science

The daily digest

Today's best Hacker News stories, summarized and screenshotted, one email a day.